Skip to Content

Press Release

Rep. Cuellar Announces $360,529 for Atascosa Health Center’s Efforts to Expand COVID-19 Testing

Funding will be used to increase testing capabilities in Atascosa, Wilson and McMullen Counties

Washington | Charlotte Laracy, DC Press Secretary (202-226-1583); Alexis Torres, District Press Secretary (956-286-6007), May 7, 2020

Pleasanton, TX-- Congressman Henry Cuellar (TX-28) announced $360,529 in federal funding for the Atascosa Health Center’s efforts  to combat the coronavirus pandemic. This funding, awarded through the Department of Health and Human Services, will be used to increase testing capabilities to help track the spread and impact of the coronavirus in Atascosa, Wilson, and McMullen counties.

“As we take steps to reopen Texas, it is critical that our health centers have the necessary resources to implement an aggressive testing strategy,” said Congressman Cuellar.This federal investment will be used to support Atascosa Health Center and their work to make COVID-19 testing easy and accessible throughout our community.”

As a member of the Bipartisan White House Task Force, I will continue to fight for the necessary funding to combat this public health crisis and eventually, fully reopen the Lone Star State and the rest of the country. I would like to thank Monty Small, CEO of Atascosa Health Center, and the rest of his staff for their dedication to providing care during this unprecedented public health crisis.”

As a senior member of the Appropriations Committee, Congressman Cuellar helped secure $825 million for health centers funded by Health Resources and Services Administration (HRSA) in the Paycheck Protection Program and Health Care Enhancement Act. Atascosa Health Center will use this funding to expand the range of testing and testing-related activities to best address the needs of their local communities, including the purchase of personal protective equipment; training, outreach, procurement and administration of tests; laboratory services; and the expansion of walk-up or drive-up testing capabilities.